CN Patent

CN108712909A — 奥利万星制剂

Assigned to Melinta Subsidiary Corp · Expires 2018-10-26 · 8y expired

What this patent protects

本文公开了包含奥利万星或其盐和经修饰的β‑环糊精的抗细菌药物组合物，及其治疗用途和制备。

USPTO Abstract

本文公开了包含奥利万星或其盐和经修饰的β‑环糊精的抗细菌药物组合物，及其治疗用途和制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN108712909A
Jurisdiction
CN
Classification
—
Expires
2018-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Melinta Subsidiary Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.